Quick Answer
Sonoma Pharmaceuticals, Inc. reported Stockholders Equity of $4.41 million for the year ending 2025.
- Sonoma Pharmaceuticals, Inc. showed a decrease of -28.1% in Stockholders Equity from 2024 to 2025.
- This data is from Sonoma Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on June 17, 2025.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2014: $13.37 million | Q4 2014: $7.83 million | Q2 2015: $11.14 million | Q3 2015: $10.75 million | Q4 2015: $9.12 million | Q2 2016: $7.75 million | Q3 2016: $6.04 million | Q4 2016: $22.86 million | Q2 2017: $18.61 million | Q3 2017: $16.16 million | Q4 2017: $14.26 million | Q2 2018: $12.63 million | Q3 2018: $10.79 million | Q4 2018: $13.34 million | Q2 2019: $11.50 million | Q3 2019: $10.27 million | Q4 2019: $11.21 million | Q2 2020: $10.67 million | Q3 2020: $11.56 million | Q4 2020: $12.32 million | Q2 2021: $4.62 million | Q3 2021: $11.46 million | Q4 2021: $11.17 million | Q2 2022: $7.96 million | Q3 2022: $7.02 million | Q4 2022: $5.56 million | Q2 2023: $7.24 million | Q3 2023: $5.68 million | Q4 2023: $6.69 million | Q1 2024: $6.14 million | Q2 2024: $4.98 million | Q3 2024: $5.35 million | Q4 2024: $4.87 million | Q1 2025: $4.41 million | Q2 2025: $4.06 million | Q3 2025: $3.79 million | Q4 2025: $3.43 million.
- Over the full 16 years of available data (2010 to 2025), Sonoma Pharmaceuticals, Inc.'s Stockholders Equity has declined by 37.4%.
- Historical annual values: Fiscal year 2025: $4.41 million | Fiscal year 2024: $6.14 million | Fiscal year 2023: $7.98 million | Fiscal year 2022: $8.70 million | Fiscal year 2021: $5.36 million | Fiscal year 2020: $5.62 million | Fiscal year 2019: $7.77 million | Fiscal year 2018: $15.33 million | Fiscal year 2017: $21.43 million | Fiscal year 2016: $10.14 million | Fiscal year 2015: $12.05 million | Fiscal year 2014: $12.06 million | Fiscal year 2013: $4.08 million | Fiscal year 2012: -$868.0 thousand | Fiscal year 2011: $1.70 million | Fiscal year 2010: $7.05 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: